がん臨床意思決定ツールの世界市場レポート 2024

がん臨床意思決定ツールの市場規模は、今後数年間で急速に成長すると予想されます。 2028年には9.6%の年間平均成長率（CAGR）で7億2,000万米ドルに成長すると予想されます。今後の成長が予想されるのは、いくつかの重要な要因によるものと考えられます。これらには世界の人口高齢化が含まれており、高齢者のヘルスケアアニーズとがんケアへの関心が高まっています。さらに、患者を治療計画にもっと積極的に参加させることを目的として、患者の関与と意思決定の共有がますます重視されています。患者中心のケアへのこの移行は、がん治療方法の進歩を形作ると期待されています。

世界のがん症例の増加により、がん臨床意思決定ツール市場の成長が加速する傾向にあります。 2022年 1月に米国がん協会が強調したように、米国だけでも190万人が新たにがんと診断され、約609,360人ががん関連で死亡し、毎日約1,670人が死亡していると推定されています。肺がん、前立腺がん、腸がん、および女性の乳がんは、合計すると世界中の新規がん症例の43%を占めます。この世界のがん事件の急増により、がん臨床意思決定ツールの需要が高まり、治療法の決定が迅速化され、それによってこれらのツールの市場が拡大すると予測されています。

ヘルスケアIT導入の急増は、がん臨床意思決定ツール市場の原動力となると予想されます。ヘルスケアITの導入は、ヘルスケア領域内での情報技術ソリューションの同化と使用を意味します。医療機関は、患者ケアの最適化を目指して、電子医療記録（EHR）や臨床意思決定支援システム（CDSS）を含む情報技術に戦略的に投資しています。これらのシステムは、リアルタイムの患者データ、治療ガイドライン、潜在的な問題に対する警告メカニズムを統合し、最終的にがん治療の成果を向上させます。たとえば、2022年 1月にヘルスケア情報管理システム協会（HIMSS）が発行したレポートでは、ヘルスケア提供者のかなりの80%が今後5年間でテクノロジーへの投資を拡大する予定であることが示されています。ヘルスケアIT導入のこの傾向は、がん臨床意思決定ツール市場の成長軌道を推進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界のがん臨床意思決定ツール市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• リスク評価ツール（RAT）
• Qcancer
• 世界のがん臨床意思決定ツール市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• クリニック

第7章 地域および国の分析

• 世界のがん臨床意思決定ツール市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界のがん臨床意思決定ツール市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• がん臨床意思決定ツール市場の競合情勢
• がん臨床意思決定ツール市場の企業プロファイル
  • McKesson Corporation
  • Medical Information Technology Inc.
  • Philips Healthcare
  • Siemens Healthineers AG
  • Elsevier BV

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

Cancer clinical decision tools are instrumental aids designed to support medical practitioners in identifying potential signs and symptoms of cancer, enabling more effective patient treatment. These tools play a crucial role in clinical decision-making by assisting General Practitioners (GPs) in determining whether further diagnostic testing or referrals are necessary for patients suspected of having cancer.

Among the primary types of cancer clinical decision tools are risk assessment tools (RAT) and Qcancer. Risk assessment tools evaluate a combination of risk factors, encompassing genetic, environmental, and behavioral elements, to translate these factors into estimations of an individual's likelihood of developing specific types of cancer. These tools serve to streamline risk models and facilitate assessments of an individual's cancer risk profile. These cancer clinical decision tools find application across various healthcare settings, including hospitals and clinics, supporting healthcare professionals in making informed decisions regarding patient care and potential referrals for further diagnostic assessments.

The cancer clinical decision tools market research report is one of a series of new reports from The Business Research Company that provides cancer clinical decision tools market statistics, including cancer clinical decision tools industry global market size, regional shares, competitors with a cancer clinical decision tools market share, detailed cancer clinical decision tools market segments, market trends and opportunities, and any further data you may need to thrive in the cancer clinical decision tools industry. This cancer clinical decision tools market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cancer clinical decision tools market size has grown rapidly in recent years. It will grow from $0.45 billion in 2023 to $0.5 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth observed in the historical period can be attributed to several key factors. These include the escalating prevalence of cancer cases, the heightened complexity in cancer treatment methodologies, a growing demand for personalized medicine tailored to individual patient needs, an increased adoption of value-based healthcare models emphasizing patient outcomes, the expanding availability and utilization of comprehensive cancer-related data, and significant governmental support for cancer research and development initiatives. These elements collectively contributed to the growth and advancements in cancer care, fostering innovation and improvements in treatment strategies.

The cancer clinical decision tools market size is expected to see rapidly grown in the next few years. It will grow to $0.72 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The anticipated growth in the upcoming period can be attributed to several key factors. These include the global aging population, fostering a heightened focus on healthcare needs and cancer care among elderly individuals. Additionally, there's an increasing emphasis on patient engagement and shared decision-making, aiming to involve patients more actively in their treatment plans. This shift towards patient-centric care is expected to shape advancements in cancer treatment methodologies.

The ascending global cancer cases are poised to fuel growth in the cancer clinical decision tools market. As highlighted by the American Cancer Society in January 2022, the US alone is estimated to witness 1.9 million new cancer diagnoses and approximately 609,360 cancer-related deaths, translating to roughly 1,670 fatalities daily. Lung, prostate, bowel, and female breast cancers collectively account for 43% of all new cancer cases worldwide. This surge in cancer incidents globally is projected to intensify the demand for cancer clinical decision tools, expediting treatment decisions and thereby bolstering the market for these tools.

The proliferation of healthcare IT adoption is anticipated to be a driving force behind the cancer clinical decision tools market. Healthcare IT adoption denotes the assimilation and usage of information technology solutions within the healthcare domain. Health institutions strategically invest in information technology, encompassing electronic health records (EHRs) and clinical decision support systems (CDSS), aiming to optimize patient care. These systems integrate real-time patient data, treatment guidelines, and alert mechanisms for potential issues, ultimately enhancing cancer treatment outcomes. For example, a report published by the Healthcare Information and Management Systems Society (HIMSS) in January 2022 indicated that a significant 80% of healthcare providers planned to augment their technology investments over the next five years. This trend in healthcare IT adoption is expected to propel the cancer clinical decision tools market's growth trajectory.

Key industry players in the cancer clinical decision tools market are exploring innovative offerings like the BenchMark Ultra Plus tissue staining system to gain a competitive edge. This advanced system streamlines tissue staining, enabling quicker and more accurate pathology outcomes. Launched by F. Hoffmann-La Roche AG in June 2022, the BenchMark Ultra Plus system showcases enhanced workflow efficiency, testing processes, and sustainability attributes. This innovation empowers pathologists to deliver high-quality, time-sensitive results to medical professionals and patients alike. The BenchMark Ultra Plus system marks a significant advancement in the BenchMark series, automating erstwhile manual slide-by-slide processes and revolutionizing cancer diagnostics.

In March 2021, NeoGenomics Laboratories, Inc., an American firm specializing in cancer genetics diagnostic testing and related services, completed the acquisition of Trapelo Health, LLC., for a total of $65 million. This strategic acquisition aims to bolster NeoGenomics' capabilities in precision oncology. By leveraging Trapelo Health's innovative decision-support platform, NeoGenomics intends to streamline diagnostic and treatment selection processes for healthcare professionals, laboratories, and payers. The platform facilitates real-time access to current clinical data, expedites workflow, and enhances clinical trial matching, ultimately offering patients improved access to medically suitable therapy options.

Major companies operating in the cancer clinical decision tools market include McKesson Corporation, Medical Information Technology Inc., Philips Healthcare, Siemens Healthineers AG, Elsevier B.V., Macmillan Publishers Limited, National Decision Support Company, IBM Watson Health, Cerner Corporation, GE Healthcare, Allscripts Healthcare Solutions Inc., Epic Systems Corporation, Koninklijke Philips N.V., RaySearch Laboratories AB, Elekta AB, Varian Medical Systems Inc., Accuray Incorporated, F. Hoffmann-La Roche Ltd., Flatiron Health Inc., Tempus Labs Inc., NantHealth Inc., Syapse Inc., Inspirata Inc., Oncora Medical Inc., Prognos Health Inc., Deep 6 AI Inc., PathAI Inc., Enlitic Inc., Ibex Medical Analytics Ltd., Zebra Medical Vision Ltd., Aidoc Medical Ltd.

North America was the largest region in the cancer clinical decision tools market in 2023. The regions covered in the cancer clinical decision tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The countries covered in the cancer clinical decision tools market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The market for cancer clinical decision tools consists of sales of risk assessment tools, Q-Cancer tools, and MacMillan's cancer decision tool. Values in this market are 'factory gate values,' that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cancer Clinical Decision Tools Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cancer clinical decision tools market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cancer clinical decision tools? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cancer clinical decision tools market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Risk Assessment Tool(RAT); Qcancer
• 2) By End-User: Hospital; Clinics
• Companies Mentioned: McKesson Corporation; Medical Information Technology Inc.; Philips Healthcare; Siemens Healthineers AG; Elsevier B.V.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cancer Clinical Decision Tools Market Characteristics

3. Cancer Clinical Decision Tools Market Trends And Strategies

4. Cancer Clinical Decision Tools Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On the Market
• 4.2. Ukraine-Russia War Impact On the Market
• 4.3. COVID-19 Impact On the Market

5. Global Cancer Clinical Decision Tools Market Size and Growth

• 5.1. Global Cancer Clinical Decision Tools Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Cancer Clinical Decision Tools Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Cancer Clinical Decision Tools Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cancer Clinical Decision Tools Market Segmentation

• 6.1. Global Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Risk Assessment Tool(RAT)
• Qcancer
• 6.2. Global Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital
• Clinics

7. Cancer Clinical Decision Tools Market Regional And Country Analysis

• 7.1. Global Cancer Clinical Decision Tools Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Cancer Clinical Decision Tools Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cancer Clinical Decision Tools Market

• 8.1. Asia-Pacific Cancer Clinical Decision Tools Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cancer Clinical Decision Tools Market

• 9.1. China Cancer Clinical Decision Tools Market Overview
• 9.2. China Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cancer Clinical Decision Tools Market

• 10.1. India Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cancer Clinical Decision Tools Market

• 11.1. Japan Cancer Clinical Decision Tools Market Overview
• 11.2. Japan Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cancer Clinical Decision Tools Market

• 12.1. Australia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cancer Clinical Decision Tools Market

• 13.1. Indonesia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cancer Clinical Decision Tools Market

• 14.1. South Korea Cancer Clinical Decision Tools Market Overview
• 14.2. South Korea Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cancer Clinical Decision Tools Market

• 15.1. Western Europe Cancer Clinical Decision Tools Market Overview
• 15.2. Western Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cancer Clinical Decision Tools Market

• 16.1. UK Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cancer Clinical Decision Tools Market

• 17.1. Germany Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cancer Clinical Decision Tools Market

• 18.1. France Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cancer Clinical Decision Tools Market

• 19.1. Italy Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cancer Clinical Decision Tools Market

• 20.1. Spain Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cancer Clinical Decision Tools Market

• 21.1. Eastern Europe Cancer Clinical Decision Tools Market Overview
• 21.2. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cancer Clinical Decision Tools Market

• 22.1. Russia Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cancer Clinical Decision Tools Market

• 23.1. North America Cancer Clinical Decision Tools Market Overview
• 23.2. North America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cancer Clinical Decision Tools Market

• 24.1. USA Cancer Clinical Decision Tools Market Overview
• 24.2. USA Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cancer Clinical Decision Tools Market

• 25.1. Canada Cancer Clinical Decision Tools Market Overview
• 25.2. Canada Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cancer Clinical Decision Tools Market

• 26.1. South America Cancer Clinical Decision Tools Market Overview
• 26.2. South America Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cancer Clinical Decision Tools Market

• 27.1. Brazil Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cancer Clinical Decision Tools Market

• 28.1. Middle East Cancer Clinical Decision Tools Market Overview
• 28.2. Middle East Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cancer Clinical Decision Tools Market

• 29.1. Africa Cancer Clinical Decision Tools Market Overview
• 29.2. Africa Cancer Clinical Decision Tools Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Cancer Clinical Decision Tools Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cancer Clinical Decision Tools Market Competitive Landscape And Company Profiles

• 30.1. Cancer Clinical Decision Tools Market Competitive Landscape
• 30.2. Cancer Clinical Decision Tools Market Company Profiles
  • 30.2.1. McKesson Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Medical Information Technology Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Philips Healthcare
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Siemens Healthineers AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Elsevier B.V.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Global Cancer Clinical Decision Tools Market Competitive Benchmarking

32. Global Cancer Clinical Decision Tools Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Cancer Clinical Decision Tools Market

34. Cancer Clinical Decision Tools Market Future Outlook and Potential Analysis

• 34.1 Cancer Clinical Decision Tools Market In 2028 - Countries Offering Most New Opportunities
• 34.2 Cancer Clinical Decision Tools Market In 2028 - Segments Offering Most New Opportunities
• 34.3 Cancer Clinical Decision Tools Market In 2028 - Growth Strategies
  • 34.3.1 Market Trend Based Strategies
  • 34.3.2 Competitor Strategies

35. Appendix

• 35.1. Abbreviations
• 35.2. Currencies
• 35.3. Historic And Forecast Inflation Rates
• 35.4. Research Inquiries
• 35.5. The Business Research Company
• 35.6. Copyright And Disclaimer